Maxalt Melt Wafers

Maxalt Wafers are an orodispersible form of rizatriptan, a prescription triptan medicine used to treat migraine attacks once they've started. Each wafer dissolves on the tongue within seconds, without needing water, and is then swallowed with saliva. The wafers come in two strengths, 5 mg and 10 mg, in moisture-resistant blister packs. They're made by Organon (originally Merck) under the brand name Maxalt Melt in the UK, and they contain the same active ingredient (rizatriptan benzoate) as the regular Maxalt tablets, just in a different format.

Yes. "Maxalt Wafers" and "Maxalt Melt" are two names for the same product in the UK, used somewhat interchangeably by patients, prescribers, and pharmacists. The official brand name on UK packaging is Maxalt Melt, but the product is often referred to as "wafers" because of how it looks and feels (a thin, round, fast-dissolving disc). If your prescription says Maxalt Melt and the pharmacy hands you something labelled wafers, or vice versa, it's the same medicine. Generic rizatriptan orodispersible wafers are also available and contain the same active ingredient at the same strengths.

The active ingredient, dose options, and overall effect on a migraine are the same. The differences are practical rather than pharmacological. Regular Maxalt tablets need to be swallowed with water like any standard tablet. Maxalt Wafers dissolve on the tongue in a few seconds and can be taken without water, which makes them useful in three particular situations: when you're already feeling sick and the idea of swallowing a tablet with water is unappealing; when you're somewhere without easy access to water (in a meeting, on a plane, in bed in the middle of the night); and when you have any general difficulty with swallowing tablets. The wafers also have a more discreet feel, since you can take one without anyone noticing you've reached for water. The trade-off is that wafers tend to be slightly more expensive than standard tablets, and the aspartame they contain is a consideration for a small group of patients (covered below). For most people who can swallow tablets comfortably and have water available, the standard Maxalt tablet works equally well; the wafer is a useful alternative rather than an inherently better product.

This is one of the most common misconceptions about orodispersible medicines, and it's worth correcting clearly. Maxalt Wafers do not work faster than regular Maxalt tablets, despite the fact that they dissolve in your mouth in seconds. The reason is that rizatriptan isn't significantly absorbed through the lining of the mouth or under the tongue. After the wafer dissolves, the medicine is swallowed with saliva and absorbed through the stomach and small intestine, just like a regular tablet. The onset of action is therefore similar: around 30 minutes from taking the medicine to noticeable pain relief, with peak effect at around 1 to 1.5 hours. The advantage of the wafer is convenience and tolerability when nauseated, not speed. If you specifically need a faster-acting migraine treatment, sumatriptan nasal spray (around 15 minutes onset) or sumatriptan injection (10 to 15 minutes onset) are the genuinely faster options.

The wafers are quite delicate and sensitive to moisture, so the handling matters more than with regular tablets. Keep them in the original blister pack until you're ready to use one; the foil seal protects them from the air. When you need a dose, peel the foil back from a single blister with dry hands rather than pushing the wafer through. Pushing risks breaking the wafer, since it's much thinner and softer than a tablet. Take the wafer out, place it on your tongue, close your mouth, and let it dissolve. This usually takes only a few seconds. There's no need to swallow water, though you can do so afterwards if you prefer. The wafer has a mild peppermint flavour that most people find inoffensive. Don't store wafers in a damp environment (like a bathroom cabinet near a shower), and don't decant them into pill organisers, because they degrade quickly once exposed to air.

Migraine isn't a regular headache. During an attack, blood vessels in the head dilate, and a set of nerves around those vessels (the trigeminal nerves) release inflammatory chemicals that cause throbbing pain, nausea, sensitivity to light and sound, and the other classic migraine symptoms. Rizatriptan works on receptors called 5-HT1B and 5-HT1D, which sit on those dilated vessels and on the nerve endings around them. Activating 5-HT1B receptors causes the dilated vessels to constrict back to their normal size. Activating 5-HT1D receptors stops the trigeminal nerves releasing the inflammatory chemicals that drive the pain. The result is that the migraine attack is interrupted at its source rather than just having the pain dulled. This explains why triptans like rizatriptan can stop a migraine outright in many people, where simple painkillers can only take the edge off.

As early as possible after the headache phase begins. This is one of the most consistent findings in migraine research: triptans work much better when taken at the first sign of head pain than once a migraine is fully established. The wafer format makes early dosing easier, because you don't need to be near water or able to swallow a tablet comfortably. Many people with regular migraines learn to recognise the earliest signals: a slight visual disturbance, a dull ache behind one eye, a strange stiffness in the neck, or a sense that "something's coming". Acting at that point can often abort the attack entirely. Waiting until you're vomiting and lying down in a dark room reduces the chance of a good response significantly. If you have an aura before your headache, the usual advice is to wait until the headache itself starts before taking the wafer, because the aura phase doesn't respond to triptans.

The standard starting dose is 10 mg (one 10 mg wafer) at the onset of the headache. If the migraine comes back within 24 hours after an initial response, a second dose can be taken at least 2 hours after the first, up to a maximum of 20 mg in 24 hours. There's one important exception to the standard dose, and it's specific to rizatriptan: if you're taking propranolol (the most commonly prescribed migraine preventive), the dose must be reduced to 5 mg, with a maximum of 10 mg in 24 hours. Propranolol significantly raises rizatriptan blood levels, and the reduced dose accounts for this. Make sure your prescriber knows about all your other medicines for this reason. The same dose applies to wafers as to tablets, because the absorption is essentially the same.

Most people tolerate Maxalt Wafers well, but rizatriptan produces a fairly distinctive set of effects sometimes called "triptan sensations". These include tingling, a feeling of warmth or coolness, mild flushing, and a sense of pressure or tightness that can be felt in the chest, throat, neck, jaw, or limbs. The chest tightness in particular tends to alarm people the first time they experience it, because the natural assumption is that it's something cardiac. In healthy people without heart disease this sensation isn't dangerous and reflects the medicine's action on blood vessels and smooth muscle. It usually settles within 30 minutes to an hour. That said, real cardiac chest pain can also occur in someone with undiagnosed heart disease who takes a triptan, so the distinction matters. If the chest sensation is severe, prolonged, crushing, associated with breathlessness, or radiating down the arm, that needs urgent assessment rather than being assumed to be a "triptan sensation". Other common side effects include drowsiness, dizziness, fatigue, dry mouth, and nausea.

Maxalt Wafers contain aspartame as a sweetener, which gives them their slightly sweet, palatable taste. For almost everyone, aspartame at the small amounts used in a medicine wafer is fine. The one group for whom it matters is people with phenylketonuria (PKU), an inherited metabolic condition in which the body can't break down phenylalanine, one of the components of aspartame. People with PKU need to know that each wafer contains a small amount of phenylalanine and should discuss this with their metabolic team or GP before using them, particularly if they're managing their condition with a low-phenylalanine diet. If you don't have PKU (and most people don't, since it's a rare condition usually picked up by newborn screening), the aspartame isn't a clinical concern. Beyond the PKU point, the aspartame is also worth knowing about if you've had a strong reaction to artificial sweeteners in the past or simply prefer to avoid them, in which case the standard Maxalt tablet may suit you better.

A few interactions matter. Maxalt Wafers should not be taken with monoamine oxidase inhibitor antidepressants (MAOIs) or within two weeks of stopping one, because the combination can cause dangerous rises in blood pressure and serotonin syndrome. They shouldn't be taken with another triptan or with ergotamine-type migraine medicines on the same day, because the vasoconstriction effects can add up. As mentioned above, propranolol significantly raises rizatriptan blood levels and requires the 5 mg dose. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs), such as sertraline, citalopram, or venlafaxine, carry a small theoretical risk of serotonin syndrome when combined with triptans, though in practice this is rare. On the heart problems question, rizatriptan causes blood vessel constriction including in the coronary arteries that supply the heart muscle, so it's contraindicated in established ischaemic heart disease, previous heart attack, coronary artery vasospasm (Prinzmetal's angina), uncontrolled high blood pressure, previous stroke, and peripheral vascular disease. It's also used with caution in people who don't have known heart disease but carry significant cardiovascular risk factors (men over 40, postmenopausal women, smokers, diabetes, raised cholesterol, family history of premature heart disease). In those situations a cardiovascular assessment before starting any triptan is often recommended.

The safety data for rizatriptan in pregnancy is more limited than for sumatriptan, partly because sumatriptan has been on the market longer and has accumulated more registry data. What evidence exists doesn't show clear harm, but most clinicians prefer sumatriptan in pregnancy where a triptan is needed, because of the larger safety database. If you're pregnant and considering Maxalt Wafers, the conversation is worth having with your GP rather than self-managing. In breastfeeding, rizatriptan passes into breast milk in small amounts, and the standard advice is to avoid breastfeeding for 24 hours after a dose. Many women express and discard breast milk during that window to maintain supply.

This is one of the most important things to understand about triptans, because the danger isn't using them, it's using them too often. Medication overuse headache (MOH) is a surprisingly common problem in which the body's response to frequent triptan use becomes paradoxical: the medicines that were helping start producing rebound headaches, which then prompt more medicine use, in a cycle that can become entrenched. The current threshold is taking a triptan on more than 10 days a month, on average, for three or more months. Above that level, the risk of MOH rises significantly. If you find yourself reaching for Maxalt Wafers 10 or more days a month, that's a strong signal that the conversation needs to shift from acute treatment to preventive treatment, which is a different category of medicine designed to reduce how often migraines happen in the first place. Treatment of medication overuse headache, somewhat counter-intuitively, involves stopping the overused medicine for a period to allow the headache pattern to reset, often with specialist guidance.

Several features call for prompt medical review rather than continuing on Maxalt Wafers alone. A first-ever severe headache, particularly one that comes on suddenly or feels different from anything you've had before, can be a warning of a more serious condition like meningitis or subarachnoid haemorrhage and should be treated as an emergency. Migraine lasting more than 72 hours without responding to treatment ("status migrainosus") needs medical assessment. New neurological symptoms during a migraine, such as one-sided weakness, slurred speech, or confusion that doesn't fit your usual aura pattern, also need urgent review. Headaches that wake you from sleep, headaches that consistently get worse over weeks, or headaches with weight loss, fever, or other systemic symptoms warrant assessment. Beyond the red flags, a clinical review is worth having if your migraines are happening often, if Maxalt Wafers aren't enough, if you're using them on more than 10 days a month, or if you've never had a formal migraine diagnosis. Modern migraine care has changed considerably in the last decade with the arrival of CGRP-targeted preventive medicines, and many people who've been managing on triptans alone for years find that a proper review opens up better options.